文献速递白血病

全基因组测序为儿童B细胞急性淋巴细胞白血病提供全面基因检测

Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.
PubMed 文献 · Leukemia · 2023-01-19

本研究对210例儿童B细胞急性淋巴细胞白血病(B-ALL)样本进行全基因组测序(WGS),设计分子分型系统识别关键遗传改变。WGS在96%(202/210)患者中检出294个亚型定义性遗传异常,与标准方法和全转录组测序结果一致,并扩展了PAX5alt和ETV6::RUNX1样亚型的遗传图谱,改进了DUX4重排的检测。

要点

  • WGS在96%(202/210)儿童B-ALL中检出294个亚型定义性遗传异常。
  • WGS结果与标准诊疗方法和全转录组测序一致。
  • 新生物信息学流程改进DUX4重排检测,该亚型生存率高。

核心结论

  • WGS可作为独立、可靠的基因检测方法,检测B-ALL所有亚型定义性遗传异常,准确进行风险导向治疗分层,同时作为研究工具识别新疾病生物标志物。

研究设计与样本

  • 对210例有临床和遗传数据注释的儿童B-ALL样本进行全基因组测序,基于肿瘤-正常和肿瘤-only分析中关键遗传改变设计分子分型系统。

主要发现

  • 在96%(202/210)患者中检出294个亚型定义性遗传异常。
  • 发现新遗传变异,包括涉及MAP激酶通路基因的融合。
  • WGS结果与标准诊疗方法和全转录组测序一致。
  • 扩展了可可靠分类PAX5alt和ETV6::RUNX1样亚型的遗传图谱。
  • 新生物信息学流程改进DUX4重排检测,DUX4-r为预后良好、生存率高的B-ALL亚型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Childhood B-cell acute lymphoblastic leukaemia (B-ALL) is characterised by recurrent genetic abnormalities that drive risk-directed treatment strategies. Using current techniques, accurate detection of such aberrations can be challenging, due to the rapidly expanding list of key genetic abnormalities. Whole genome sequencing (WGS) has the potential to improve genetic testing, but requires comprehensive validation. We performed WGS on 210 childhood B-ALL samples annotated with clinical and genetic data. We devised a molecular classification system to subtype these patients based on identification of key genetic changes in tumour-normal and tumour-only analyses. This approach detected 294 subtype-defining genetic abnormalities in 96% (202/210) patients. Novel genetic variants, including fusions involving genes in the MAP kinase pathway, were identified. WGS results were concordant with standard-of-care methods and whole transcriptome sequencing (WTS). We expanded the catalogue of genetic profiles that reliably classify PAX5alt and ETV6::RUNX1-like subtypes. Our novel bioinformatic pipeline improved detection of DUX4 rearrangements (DUX4-r): a good-risk B-ALL subtype with high survival rates. Overall, we have validated that WGS provides a standalone, reliable genetic test to detect all subtype-defining genetic abnormalities in B-ALL, accurately classifying patients for the risk-directed treatment stratification, while simultaneously performing as a research tool to identify novel disease biomarkers.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Ryan SL, Peden JF, Kingsbury Z, et al. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia. Leukemia. 2023. PMID: 36658389. doi:10.1038/s41375-022-01806-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。